(all numbers are approximations; sources provided
Post# of 148179
(Total Views: 645)
Posted On: 04/05/2020 1:26:02 AM
(all numbers are approximations; sources provided for greater accuracy)
using NY as a case study, they've had 113,700 cases identified. 15,900 are hospitalized. that's roughly 14% of those tested. 4,125 are in ICU. See https://nymag.com/intelligencer/article/new-y...dates.html
So if we look at the entire country, it's 277,200 as of 4/4 per the CDC. If we use 14%, we're at 39,000 hospitalizations. if treatment consists of only 2 weekly treatments, that's 78,000 vials. but we can clearly see that the rest of the country isn't tracking the same curve that NY and other hotspots are tracking. so I think 14% might be high. i'm pretty confident CYDY can easily meet DOMESTIC demand.
Now, since they're also testing in mild/moderate cases, we could easily capture half of those cases or about 43% of total cases (100-14=86/2 =43% of total cases). why only half? 1. BP isn't just going to sit around and watch. 2. the pres is big on Hydroxychloroquine and 3. many doctors just won't trust Leronlimab. it's never as easy as one thinks to penetrate markets. plus, you have to factor in how many do just fine staying home, isolated. I’m guessing it’s pretty high. In NY, 10,000+ have been discharged. Not sure If NY’s “total cases” is just those that are presently diagnosed or if that includes all those that were diagnosed in the past but are now c-19 free. if we had some clarity on that number we might be able to tighten numbers more.
The real challenge will be filling orders for the rest of the globe. I'm sure someone else could take the above numbers and apply to the ROW.
poor EvrBlt. still whining, huh. stick to CYDY and we'll be just fine. start attacking me and we'll have problems. simple.
using NY as a case study, they've had 113,700 cases identified. 15,900 are hospitalized. that's roughly 14% of those tested. 4,125 are in ICU. See https://nymag.com/intelligencer/article/new-y...dates.html
So if we look at the entire country, it's 277,200 as of 4/4 per the CDC. If we use 14%, we're at 39,000 hospitalizations. if treatment consists of only 2 weekly treatments, that's 78,000 vials. but we can clearly see that the rest of the country isn't tracking the same curve that NY and other hotspots are tracking. so I think 14% might be high. i'm pretty confident CYDY can easily meet DOMESTIC demand.
Now, since they're also testing in mild/moderate cases, we could easily capture half of those cases or about 43% of total cases (100-14=86/2 =43% of total cases). why only half? 1. BP isn't just going to sit around and watch. 2. the pres is big on Hydroxychloroquine and 3. many doctors just won't trust Leronlimab. it's never as easy as one thinks to penetrate markets. plus, you have to factor in how many do just fine staying home, isolated. I’m guessing it’s pretty high. In NY, 10,000+ have been discharged. Not sure If NY’s “total cases” is just those that are presently diagnosed or if that includes all those that were diagnosed in the past but are now c-19 free. if we had some clarity on that number we might be able to tighten numbers more.
The real challenge will be filling orders for the rest of the globe. I'm sure someone else could take the above numbers and apply to the ROW.
poor EvrBlt. still whining, huh. stick to CYDY and we'll be just fine. start attacking me and we'll have problems. simple.
(6)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼